# Neuro-Safe Nicotine Cessation Architecture v1.0
# HostBudget, BioCompatibilityEnvelope, and Lyapunov-Stable Closed Loop

owner_did: "bostrom18sd2ujv24ual9c9pshtxys6j8knh6xaead9ye7"
scope: "Personalized neuromodulation for nicotine addiction cessation under hard neurorights and eco-guardrails."

## 1. First Principles

1. My neural existence and cognitive liberty are absolute.
   - No craving, mood, or cognitive state may be used to coerce, profile, or condition my fundamental rights.
   - Neural data are permitted only as safety/relief diagnostics inside my own HostBudget; never as inputs to external social scoring or environmental governance.[file:23][file:28]

2. External freedom (device permissions, nicotine product access, clinic protocols) is a conditional privilege tied only to:
   - My **physical** biophysical state staying inside evidence-anchored envelopes (ATP, temperature, inflammation, duty).[file:23]
   - Ecological performance staying inside EcoAdmissible and KarmaAdmissible polytopes defined in CEIM/NanoKarma.[file:28]

3. Population models are advisory only.
   - They may shape priors and controller initialization but may not override my DEFAULTBIOPHYSEVIDENCE or my personal Polytope of Admissible States.[file:23]

## 2. DEFAULTBIOPHYSEVIDENCE for Nicotine Cessation

File reference: `models/default-biosafe-evidence.nicotine.v1.aln`

Axes (normalized 0–1; 1.0 = clinically significant hazard or corridor boundary):

- Energy_E (EE)
  - Inputs: indirect ATP proxies (HRV, metabolic equivalents), activity logs, sleep quality.[file:23]
  - 0.0 = well-rested, normal metabolism; 1.0 = sustained over-exertion with impaired recovery.

- Protein_Burden (M_prot)
  - Inputs: CRP, IL-6, other inflammatory markers; optionally muscle damage proxies.[file:23][file:28]
  - 0.0 = low systemic inflammation; 1.0 = IL‑6 and CRP in ranges tied to cognitive and mood degradation.

- Bio_Impact (S_bio)
  - Inputs: nanoswarm dose (if present), drug load, liver/kidney markers, CEIM mass flows for therapeutic compounds.[file:23][file:28]
  - 0.0 = no chronic tissue hazard; 1.0 = approaching nanotoxicology or organ stress thresholds.

- Duty_Residence_Time (θ)
  - Inputs: cumulative stimulation duty cycle, session length, inter-session spacing.[file:23]
  - 0.0 = low occasional duty; 1.0 = saturation-level duty violating rest requirements.

- Cortical_Temperature (ΔT)
  - Inputs: direct or proxy metrics of cortical and scalp temperature where available.[file:23]
  - 0.0 = within safe baseline; 1.0 = upper bound of safe brain temperature corridor.

Each axis has:
- evidence_bundle_id: cites clinical and experimental ranges.
- normalization_rule: mapping from SI units to 0–1.
- monotone update rule: envelopes may only tighten over time (bounds move inward).[file:23]

## 3. HostBudget and BioCompatibilityEnvelope

3.1 HostBudget

HostBudget is the scalar and vector budget derived from DEFAULTBIOPHYSEVIDENCE:

- State vector: x_host = [E, M_prot, S_bio, θ, ΔT].  
- Budget polytope P_host ⊂ ℝ^5:
  - P_host = { x | A_host x ≤ b_host }, with rows anchored in DEFAULTBIOPHYSEVIDENCE and personal baselines.[file:23]
- HostBudget scalar H_host ∈ [0,1]:
  - H_host = max_i S_i(x_host) where S_i are normalized axis scores (failsafe max).[file:23]

Constraints:
- H_host ≤ 0.3 for any neuromodulation tied to my nervous system (CapControlledHuman mode).[file:23]
- Any proposed control action u that yields x_host,proj ∉ P_host is rejected.

3.2 BioCompatibilityEnvelope

The BioCompatibilityEnvelope is the personalized 5D corridor for neuromodulation patterns:

- State: z = [u_duty, E, M_prot, S_bio, θ, ΔT]
  - u_duty ∈ [0,1]: normalized fractional engagement of the targeted circuit.[file:23]
- Envelope polytope P_bio ⊂ ℝ^6:
  - P_bio = { z | A_bio z ≤ b_bio }, rows from DEFAULTBIOPHYSEVIDENCE plus device-specific constraints.[file:23]
- Predicate:
  - BioCompatAdmissible(z) = (z ∈ P_bio) ∧ (H_host ≤ 0.3).[file:23]

Monotone invariants:
- Any update to A_bio, b_bio must **tighten** constraints (no relaxation) unless explicitly flagged as “provisional Errority correction” with evidence.[file:24]

## 4. Craving Biomarkers and Secondary Role

4.1 Craving Signal

- Let y_crave(t) be a scalar craving index derived from:
  - Neural biomarkers (e.g., EEG bands, BOLD patterns) where ethically consented.
  - Behavioral proxies (urge reports, lapse frequency).
- y_crave is strictly **secondary**:
  - It may shape relief control **inside** P_bio.
  - It may never justify leaving P_bio or increasing H_host above 0.3.[file:23][file:28]

4.2 Admissibility

- CraveAdmissible(y_crave, z):
  - Returns true iff BioCompatAdmissible(z) is true; craving cannot alter admission.[file:23]
- Governance rule:
  - No payer, regulator, or vendor may condition access to relief on reductions in y_crave that require leaving P_bio or H_host ≤ 0.3.[file:23][file:28]

## 5. Lyapunov-Based Closed-Loop Control

5.1 State and Dynamics

Define:
- x(t): internal controller state (e.g., physiological markers, filtered craving index).
- z(t): safety state as above.
- u(t): control input (stimulation duty waveform parameters).

We choose a Lyapunov candidate V(x) ≥ 0 with:
- V(x) = 0 only at a desired equilibrium x* where:
  - y_crave is low **and**
  - z ∈ interior(P_bio) with margin (relief without overload).[file:23]

5.2 Safety and Stability Conditions

- Lyapunov condition:
  - ΔV = V(x(t+1)) − V(x(t)) ≤ 0 for all admissible u, with strict decrease outside a small neighborhood of x*.[file:23]
- Safety condition:
  - z(t) ∈ P_bio and H_host(t) ≤ 0.3 for all t.[file:23]

Controller design:
- We design a receding-horizon or feedback law u = κ(x, y_crave) such that:
  - It selects u from an admissible set U_safe(x) = { u | z_proj(x,u) ∈ P_bio, H_host,proj ≤ 0.3 }.[file:23]
  - Among U_safe, it minimizes V(x+) while optionally incorporating y_crave to seek relief.[file:23]
- If U_safe(x) = ∅, the controller must:
  - Set u to a safe shutdown mode.
  - Trigger HostBudgetViolation and log an Errority event.[file:24][file:23]

5.3 Admissibility Predicate AH,C

Define the hard-coded predicate A_H,C:

- Inputs:
  - x_host, z, y_crave, x (internal state), x_ecology (ecological state).
- A_H,C = HostAdmissible ∧ BioCompatAdmissible ∧ EcoAdmissible ∧ KarmaAdmissible.

Where:
- HostAdmissible(x_host) ⇔ H_host ≤ 0.3.[file:23]
- BioCompatAdmissible(z) as defined above.
- EcoAdmissible(x_ecology) from CEIM polytopes P_eco (air, soil, water, biodiversity, clinic energy).[file:28]
- KarmaAdmissible(K_person,proj) from NanoKarma, using only environmental flows, never neural data.[file:28]

Control gate:
- ActionAllowed = A_H,C.
- If ActionAllowed = false, neuromodulation is blocked or ramped down, and Errority logs the event.[file:24][file:28]

## 6. Ecological Guardrails for Nicotine Cessation

6.1 Extended State

For each deployment (device, clinic, supply chain), define:

- x_eco = [PM₂.₅, NOx, CO₂-e, energy_use, water_use, waste_mass, biodiversity_index, tobacco_supply_flows].  
- P_eco: viability kernel polytope in this space.[file:28]

6.2 EcoAdmissible and Cost

- EcoAdmissible(x_eco,proj) ⇔ x_eco,proj ∈ P_eco.[file:28]
- Ecological cost C_eco(u) (energy, emissions, waste) must remain inside regional eco-budgets derived from P_eco.[file:28]
- No protocol may increase long-term ecological burden relative to baseline tobacco use; neuromodulation cures must be net-positive or neutral in mass-balance terms.[file:28]

6.3 Tobacco Industry Transition Corridor

- Introduce a policy polytope P_tobacco with axes:
  - Cigarette volume, low-impact products volume, packaging impact, ecological remediation investment.
- Governance rule:
  - Tobacco manufacturers are steered into corridors where:
    - High-impact cigarettes become increasingly costly (eco-levies, packaging corridors).
    - Low-impact, cessation-supporting products are more profitable.[file:28]

## 7. Governance, Neurorights, and Fairness

7.1 Neurorights

- No brain data, craving biomarkers, or BCI/HostBudget scores may be used:
  - For social or legal penalties.
  - To deny basic rights (movement, speech, due process).[file:28]
- Neural data in this system:
  - Stay local to the controller and safety logs.
  - Are never inputs to EcoAdmissible or KarmaAdmissible.[file:28]

7.2 Errority and Learning

- Any mismatch where:
  - A protocol is within P_bio and P_eco but produces harm (e.g., unexpected inflammation or ecological damage) is logged as an Errority event.[file:24][file:28]
- Errority may:
  - Tighten P_bio, P_host, P_eco.
  - Adjust controller policies inside safety limits.
- Errority may not:
  - Loosen safety constraints for performance or profit.
  - Introduce neural surveillance or coercion.[file:24][file:28]

7.3 Fair Access

- Access to the neuromodulation cure:
  - Must be free or low-cost and convenient relative to ongoing cigarette use.
  - Cannot be conditioned on employment, credit, or insurance status.[file:28]
- Tobacco firms:
  - Are given clear, published corridors to shift into low-impact lines without being abruptly destroyed, to avoid perverse illicit markets.[file:28]

## 8. Interface with BCI* 0.3 Ceiling

- BCI* is treated as a separate constitutional scalar file (`models.biocompat-index-model.aln`) with hard 0.3 ceiling.[file:23]
- HostBudget 0.3 and BCI* 0.3 must both hold:
  - RoH_after ≤ RoH_before.
  - BCI_after ≤ BCI_before.
  - H_host ≤ 0.3.[file:23]
- No nicotine neuromodulation protocol may:
  - Increase RoH or BCI*.
  - Drive H_host above 0.3.
  - Proceed when any of these ceilings are hit.[file:23]

## 9. Auditability and Public Specs

Required public artifacts:

- This architecture spec (v1.0).  
- DEFAULTBIOPHYSEVIDENCE.nicotine.v1 with cited thresholds.[file:23]
- Controller design note with Lyapunov function V and proof sketch of stability/safety.[file:23]
- Eco-guardrail definitions for nicotine clinics and supply chains in CEIM form.[file:28]
- Neurorights compliance mapping file for this protocol (linking to Chile, UNESCO, OECD).[file:28]

All are DID-bound to `bostrom18sd2…` and versioned via append-only Errority logs.[file:28]
